Cargando…
Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation
BACKGROUND: Single-stage medial meniscus allograft transplantation (MAT) with concomitant anterior cruciate ligament reconstruction (ACLR) is a technically challenging procedure for management of knee pain and instability in younger patients, but clinical and functional outcomes data are sparse. The...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832613/ https://www.ncbi.nlm.nih.gov/pubmed/36627709 http://dx.doi.org/10.1186/s43019-023-00176-4 |
_version_ | 1784868089639206912 |
---|---|
author | Shankar, Dhruv S. Vasavada, Kinjal D. Avila, Amanda DeClouette, Brittany Aziz, Hadi Strauss, Eric J. Alaia, Michael J. Jazrawi, Laith M. Gonzalez-Lomas, Guillem Campbell, Kirk A. |
author_facet | Shankar, Dhruv S. Vasavada, Kinjal D. Avila, Amanda DeClouette, Brittany Aziz, Hadi Strauss, Eric J. Alaia, Michael J. Jazrawi, Laith M. Gonzalez-Lomas, Guillem Campbell, Kirk A. |
author_sort | Shankar, Dhruv S. |
collection | PubMed |
description | BACKGROUND: Single-stage medial meniscus allograft transplantation (MAT) with concomitant anterior cruciate ligament reconstruction (ACLR) is a technically challenging procedure for management of knee pain and instability in younger patients, but clinical and functional outcomes data are sparse. The purpose of this study was to assess surgical and patient-reported outcomes following concomitant ACLR and medial MAT. METHODS: We conducted a retrospective case series of patients who underwent medial MAT with concomitant primary or revision ACLR at our institution from 2010 to 2021 and had minimum 12-month follow-up. Complications, reoperations, visual analog scale (VAS) pain, satisfaction, Lysholm score, return to sport, and return to work outcomes were assessed. Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference, Pain Intensity, and Physical Function Scores were used to measure patients’ functional status relative to the US population. P-values < 0.05 were considered significant. RESULTS: The cohort consisted of 17 knees of 16 individual patients. The cohort was majority male (82.4%) with mean age of 31.9 years (range 19–49 years) and mean body mass index (BMI) of 27.9 kg/m(2) (range 22.5–53.3 kg/m(2)). Mean follow-up time was 56.8 months (range 13–106 months). Most patients underwent revision ACLR (64.7%). The 1-year reoperation rate was high (23.5%), with two patients (11.8%) tearing their meniscus graft. Patient-reported outcomes indicated low VAS pain (mean 2.2), high satisfaction (mean 77.9%), and fair Lysholm score (mean 81.1). Return to work rate was high (92.9%), while return to sport rate was low (42.9%). Postoperative PROMIS scores were comparable or superior to the national average and correlated significantly with patient satisfaction (p < 0.05). CONCLUSIONS: The concomitant ACLR and MAT procedure is associated with excellent knee pain and functional outcomes and high rate of return to work after surgery, though the 1-year reoperation rate is high and rate of return to sport is low. Level of evidence: IV. |
format | Online Article Text |
id | pubmed-9832613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98326132023-01-12 Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation Shankar, Dhruv S. Vasavada, Kinjal D. Avila, Amanda DeClouette, Brittany Aziz, Hadi Strauss, Eric J. Alaia, Michael J. Jazrawi, Laith M. Gonzalez-Lomas, Guillem Campbell, Kirk A. Knee Surg Relat Res Research Article BACKGROUND: Single-stage medial meniscus allograft transplantation (MAT) with concomitant anterior cruciate ligament reconstruction (ACLR) is a technically challenging procedure for management of knee pain and instability in younger patients, but clinical and functional outcomes data are sparse. The purpose of this study was to assess surgical and patient-reported outcomes following concomitant ACLR and medial MAT. METHODS: We conducted a retrospective case series of patients who underwent medial MAT with concomitant primary or revision ACLR at our institution from 2010 to 2021 and had minimum 12-month follow-up. Complications, reoperations, visual analog scale (VAS) pain, satisfaction, Lysholm score, return to sport, and return to work outcomes were assessed. Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference, Pain Intensity, and Physical Function Scores were used to measure patients’ functional status relative to the US population. P-values < 0.05 were considered significant. RESULTS: The cohort consisted of 17 knees of 16 individual patients. The cohort was majority male (82.4%) with mean age of 31.9 years (range 19–49 years) and mean body mass index (BMI) of 27.9 kg/m(2) (range 22.5–53.3 kg/m(2)). Mean follow-up time was 56.8 months (range 13–106 months). Most patients underwent revision ACLR (64.7%). The 1-year reoperation rate was high (23.5%), with two patients (11.8%) tearing their meniscus graft. Patient-reported outcomes indicated low VAS pain (mean 2.2), high satisfaction (mean 77.9%), and fair Lysholm score (mean 81.1). Return to work rate was high (92.9%), while return to sport rate was low (42.9%). Postoperative PROMIS scores were comparable or superior to the national average and correlated significantly with patient satisfaction (p < 0.05). CONCLUSIONS: The concomitant ACLR and MAT procedure is associated with excellent knee pain and functional outcomes and high rate of return to work after surgery, though the 1-year reoperation rate is high and rate of return to sport is low. Level of evidence: IV. BioMed Central 2023-01-10 /pmc/articles/PMC9832613/ /pubmed/36627709 http://dx.doi.org/10.1186/s43019-023-00176-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Shankar, Dhruv S. Vasavada, Kinjal D. Avila, Amanda DeClouette, Brittany Aziz, Hadi Strauss, Eric J. Alaia, Michael J. Jazrawi, Laith M. Gonzalez-Lomas, Guillem Campbell, Kirk A. Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title | Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title_full | Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title_fullStr | Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title_full_unstemmed | Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title_short | Acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
title_sort | acceptable clinical outcomes despite high reoperation rate at minimum 12-month follow-up after concomitant arthroscopically assisted anterior cruciate ligament reconstruction and medial meniscal allograft transplantation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832613/ https://www.ncbi.nlm.nih.gov/pubmed/36627709 http://dx.doi.org/10.1186/s43019-023-00176-4 |
work_keys_str_mv | AT shankardhruvs acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT vasavadakinjald acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT avilaamanda acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT declouettebrittany acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT azizhadi acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT straussericj acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT alaiamichaelj acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT jazrawilaithm acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT gonzalezlomasguillem acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation AT campbellkirka acceptableclinicaloutcomesdespitehighreoperationrateatminimum12monthfollowupafterconcomitantarthroscopicallyassistedanteriorcruciateligamentreconstructionandmedialmeniscalallografttransplantation |